RxDoctor Payments Data

Robin Vann, MD

Ophthalmology · Durham, NCNPI 1679660054

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $188,596 of the $212,628 with a category attached, or 88.7%. Alcon accounts for 61.9% of it on its own, with 6 other manufacturers making up the rest. Among ophthalmology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$212,628in general payments, 2019–2025

Across 252 payments — averaging $843.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$132K
  • Alcon Research LLC$78K
  • Ocular Therapeutix, Inc.$3K
  • Quidel Corporation$214
  • Bausch & Lomb Americas Inc.$39
  • Carl Zeiss Meditec, Inc.$36
  • plus $31 from 1 others

What the payments were for

  • Consulting fees$188,59689%
  • Speaking & faculty fees$9,9205%
  • Travel & lodging$6,5023%
  • Food & beverage$7,3093%
  • Gifts$3020%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$212,628 in reported general payments places this provider in the 95th percentile of 588 ophthalmology providers in North Carolina.

See all ophthalmology providers in North Carolina

Medicare billing

Part B allowed, 2024
$292,822
Medicare patients
423
Services billed
1,453

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate26$794
Ketorolac Tromethamine30$490
ValacyclovirValacyclovir Hcl12$459
Ofloxacin23$243
Latanoprost11$100

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →